Your Messages Inbox
Your Article Summary
See Latest ArticlesMerck and Co., Inc. Acquires Biologic Manufacturing Capabilities and Developmental Follow-on Biologics Portfolio from Insmed
Merck & Co., 02/13/09
Merck and Co., Inc. announced that it has entered into a definitive agreement with Insmed Inc. , to purchase Insmed's portfolio of follow-on biologic therapeutic candidates and its commercial manufacturing facilities located in Boulder.
Today in Biotechnology...keeping you current
Receive free subspecialty "5-minute updates" via email
Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration
BMC: Journal of Biomedical Science, 11/30/09
ImmunoGen, Inc. Announces Clinical Data Presentations on Three TAP Compounds at Upcoming ASH Annual Meeting and Exposition
ImmunoGen, Inc., 11/25/09
ImmunoGen, Inc. Announces Second License Taken by Amgen for Right to Use the Companys TAP Technology
ImmunoGen, Inc., 11/20/09
Today in Research & Development...keeping you current
Receive free subspecialty "5-minute updates" via email
Diabetes experts underline benefits of SMBG for all types of treatment plans
BayNews International, 11/30/09
Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease
Shire, 11/30/09
Novartis inaugurates large-scale US based cell-culture influenza vaccine manufacturing facility
Novartis, 11/25/09
Article Search
Sponsor